Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy
Gamal Akabani, Ilkcan Cokgor, R. Edward Coleman, Dinko González Trotter, Terence Z. Wong, Henry S. Friedman, Allan H. Friedman, Ana Garcia-Turner, James E. Herndon, David Delong, Roger E. McLendon, Xiao Guang Zhao, Charles N. Pegram, James M. Provenzale, Darell D. Bigner, Michael R. Zalutsky
Research output: Contribution to journal › Article › peer-review
57Scopus
citations
Fingerprint
Dive into the research topics of 'Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy'. Together they form a unique fingerprint.